+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hearing Loss Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092338
Hearing loss and deafness are prevalent across the globe and exist in every country. Current estimates suggest that around 20% of the global population is living with hearing loss, with nearly 430 million of them suffering from disabling hearing loss. Further, it is projected that more than 700 million people may be affected by disabling hearing loss by 2050.

Hearing Loss Epidemiology Forecast Report Coverage

The “Hearing Loss Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of hearing loss. It projects the future incidence and prevalence rates of hearing loss across various populations. The study covers age, gender, and type as major determinants of the hearing loss-affected population. The report highlights patterns in the prevalence of hearing loss over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hearing loss in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Hearing Loss Disease Overview

Hearing loss refers to the partial or total inability to hear. It can occur in one or both ears and can be caused by various factors, including age, genetic conditions, exposure to loud noise, injury, infections, and diseases like high blood pressure or diabetes. Sensorineural hearing loss is the common hearing loss type and can occur due to aging (presbycusis), noise exposure, or genetic predisposition. Conductive hearing loss occurs when sound waves cannot reach the inner ear whereas mixed hearing loss is a combination of sensorineural and conductive hearing loss.

Hearing Loss: Treatment Overview

The treatment approach for hearing loss is based on the type, severity, and underlying cause of the condition. Hearing aids are the common treatment for sensorineural hearing loss and help in amplifying sound. Cochlear implants are used for severe sensorineural hearing loss, especially when hearing aids are not effective. Antibiotics or other medications are often prescribed for conductive hearing loss caused by infections or fluid buildup in the ear. Surgical procedures like tympanoplasty (eardrum repair) or ossiculoplasty (repair of the ossicles) are required in certain cases to restore hearing.

Epidemiology

The hearing loss epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for hearing loss by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hearing loss and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • According to the World Health Organisation (WHO), hearing loss affects over 1.5 billion people, which accounts for roughly 20% of the global population.
  • It is estimated that 430 million people are living with disabling hearing loss. By 2050, it is projected that the number of people with disabling hearing loss will increase to more than 700 million.
  • In the United States, hearing loss and/or tinnitus is the most prevalent service-connected disability among veterans, with about 2.7 million of them receiving hearing care or disability benefits related to hearing loss.
  • In the United Kingdom, nearly 900,000 individuals are severely or profoundly deaf and around 12,000 people use cochlear implants.

Country-wise Hearing Loss Epidemiology

The hearing loss epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of hearing loss varies between countries owing to differences in environmental exposures, genetics, healthcare access, and socioeconomic conditions, among others. According to the British Academy of Audiology, hearing loss is the second most common disability in the United Kingdom, with an estimated 11 million people affected by the condition in the country.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hearing loss based on several factors.
  • Hearing Loss Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of hearing loss are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of hearing loss epidemiology in the 8 major markets?
  • What will be the total number of patients with hearing loss across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of hearing loss in the 8 major markets in the historical period?
  • Which country will have the highest number of hearing loss patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of hearing loss during the forecast period of 2025-2034?
  • What are the currently available treatments for hearing loss?
  • What are the disease risks, signs, symptoms, and unmet needs of hearing loss?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Hearing Loss Market Overview - 8 MM
3.1 Hearing Loss Market Historical Value (2018-2024)
3.2 Hearing Loss Market Forecast Value (2025-2034)
4 Hearing Loss Epidemiology Overview - 8 MM
4.1 Hearing Loss Epidemiology Scenario (2018-2024)
4.2 Hearing Loss Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Hearing Loss
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Hearing Loss
7.4 Type-Specific Cases of Hearing Loss
7.5 Gender-Specific Cases of Hearing Loss
7.6 Age-Specific Cases of Hearing Loss
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in The United States
8.2 Diagnosed Prevalent Cases of Hearing Loss in The United States
8.3 Type-Specific Cases of Hearing Loss in The United States
8.4 Gender-Specific Cases of Hearing Loss in The United States
8.5 Age-Specific Cases of Hearing Loss in The United States
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in the United Kingdom
9.2 Diagnosed Prevalent Cases of Hearing Loss in the United Kingdom
9.3 Type-Specific Cases of Hearing Loss in the United Kingdom
9.4 Gender-Specific Cases of Hearing Loss in the United Kingdom
9.5 Age-Specific Cases of Hearing Loss in the United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Hearing Loss in Germany
10.3 Type-Specific Cases of Hearing Loss in Germany
10.4 Gender-Specific Cases of Hearing Loss in Germany
10.5 Age-Specific Cases of Hearing Loss in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Hearing Loss in France
11.3 Type-Specific Cases of Hearing Loss in France
11.4 Gender-Specific Cases of Hearing Loss in France
11.5 Age-Specific Cases of Hearing Loss in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Hearing Loss in Italy
12.3 Type-Specific Cases of Hearing Loss in Italy
12.4 Gender-Specific Cases of Hearing Loss in Italy
12.5 Age-Specific Cases of Hearing Loss in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Hearing Loss in Spain
13.3 Type-Specific Cases of Hearing Loss in Spain
13.4 Gender-Specific Cases of Hearing Loss in Spain
13.5 Age-Specific Cases of Hearing Loss in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Hearing Loss in Japan
14.3 Type-Specific Cases of Hearing Loss in Japan
14.4 Gender-Specific Cases of Hearing Loss in Japan
14.5 Age-Specific Cases of Hearing Loss in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Hearing Loss in India
15.3 Type-Specific Cases of Hearing Loss in India
15.4 Gender-Specific Cases of Hearing Loss in India
15.5 Age-Specific Cases of Hearing Loss in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights